Whitepapers

As has been true for many years, cancer remains the second leading cause of death in developed countries, and oncology remains the largest therapeutic area for biopharma R&D and sales. Accordingly, Lumanity has cultivated dedicated expertise in oncology across our businesses, including strategy consulting, medical affairs, medical communications, market insight, market access, and others. Lumanity has further established an Oncology Center of Excellence where our internal oncology experts across the company coordinate, collaborate, and share insights. As 2024 wrapped up, we reflected on some noteworthy trends and events and how they may continue to unfold and impact the field in 2025. We are pleased to share with you a collection of these perspectives.